Literature DB >> 3089936

Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells.

G I Byrne, L K Lehmann, G J Landry.   

Abstract

Human uroepithelial (T24) cells were incubated for 24 h in the presence of various concentrations of human recombinant gamma interferon (Hu-rIFN-gamma) and then infected with the 6BC strain of Chlamydia psittaci. This resulted in a reduction of intracellular chlamydial inclusion development in proportion to the concentration of Hu-rIFN-gamma present when Giemsa-stained cells were examined by light microscopy 24 h after infection. When tryptophan was added to Hu-rIFN-gamma-treated cells just after infection, reversal of the Hu-rIFN-gamma-mediated inhibition occurred in proportion to the concentration of tryptophan added. Addition of either isoleucine or lysine did not result in reversal of the antichlamydial state. Transport of L-[3H]tryptophan into acid-soluble intracellular pools was found to be greatly enhanced in Hu-rIFN-gamma-treated T24 cells compared with the rates measured for untreated cells. Transport of [3H]leucine was not increased in treated cells. Cells treated with Hu-rIFN-gamma also degraded L-[3H]tryptophan to catabolites that cochromatographed with N-formylkynurenine and kynurenine as measured by high-performance liquid chromatography. We conclude that Hu-rIFN-gamma-mediated inhibition of intracellular C. psittaci replication in T24 cells occurs by depletion of the essential amino acid tryptophan, most likely via the induction of indoleamine-2,3-dioxygenase, the initial enzyme of tryptophan catabolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089936      PMCID: PMC260881          DOI: 10.1128/iai.53.2.347-351.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Induction of pulmonary indoleamine 2,3-dioxygenase by interferon.

Authors:  R Yoshida; J Imanishi; T Oku; T Kishida; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

2.  Rapid separation of tryptophan, kynurenines, and indoles using reversed-phase high-performance liquid chromatography.

Authors:  S Yong; S Lau
Journal:  J Chromatogr       Date:  1979-07-13

3.  Competition between Chlamydia psittaci and L cells for host isoleucine pools: a limiting factor in chlamydial multiplication.

Authors:  T P Hatch
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  Activation of macrophages for microbicidal and tumoricidal effector functions by soluble factors from EL-4, a continuous T cell line.

Authors:  C A Nacy; S L James; W R Benjamin; J J Farrar; W T Hockmeyer; M S Meltzer
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

5.  Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages.

Authors:  G I Byrne; C L Faubion
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

6.  Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation.

Authors:  G I Byrne; C L Faubion
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

7.  Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

8.  Lymphokine enhances oxygen-independent activity against intracellular pathogens.

Authors:  H W Murray; G I Byrne; C D Rothermel; D M Cartelli
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

9.  Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.

Authors:  H W Murray; Z A Cohn
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages.

Authors:  M Sasada; R B Johnston
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

View more
  156 in total

1.  Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 2.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells.

Authors:  Robert E Molestina; Jon B Klein; Richard D Miller; William H Pierce; Julio A Ramirez; James T Summersgill
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon.

Authors:  R P Morrison
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 5.  Network genomics--a novel approach for the analysis of biological systems in the post-genomic era.

Authors:  Christian V Forst
Journal:  Mol Biol Rep       Date:  2002-09       Impact factor: 2.316

6.  Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway.

Authors:  I P Cerávolo; A C Chaves; C A Bonjardim; D Sibley; A J Romanha; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

7.  Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection.

Authors:  Jessica B Sakash; Gerald I Byrne; Andrew Lichtman; Peter Libby
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 8.  New insights into a persistent problem -- chlamydial infections.

Authors:  Richard P Morrison
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 9.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 10.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.